Literature DB >> 27277616

Contrast-enhanced sonography of pancreatic ductal carcinoma using agent detection imaging.

Naohiro Ichino1, Yuji Horiguchi2, Hideo Imai3, Keisuke Osakabe4, Tohru Nishikawa5, Yukiko Sugita5, Hideko Utsugi5, Yoko Togo5, Tomoko Sawai6, Yoshikazu Mizoguchi7.   

Abstract

PURPOSE: The aim of this study was to evaluate the enhancement behavior of pancreatic ductal carcinoma by contrast-enhanced sonography with agent detection imaging (ADI), and to clarify the origin of microbubble signals by comparisons with histological findings of resected specimens.
METHODS: The subjects were 21 patients with resectable pancreatic carcinoma. The final histological diagnosis was tubular adenocarcinoma in 20 cases, and anaplastic carcinoma in one case. Ultrasound examinations were performed using an Acuson Sequoia 512 series system, and the contrast agent (Levovist) was injected intravenously in doses of 7 ml (300 mg/ml). The ADI signals (in the tumor) were recorded continuously for 30 s after an injection of Levovist (vascular image) and then obtained intermittently (30 s time-intervals) until the signal had diminished in pancreatic tissue (perfusion image).
RESULTS: Contrast enhancement of the tumor was observed in 71.4% of subjects on the vascular image and 76.3% of subjects on the perfusion image. Enhancement patterns on the vascular image were classified into three types: VI-1 (linear enhancement), VI-2 (spotty enhancement), and VI-3 (no enhancement). VI-1, VI-2, and VI-3 were seen in 9 (42.8%), 6 (28.6%), and 6 (28.6%) of the 21 cases, respectively. Enhancement patterns on the perfusion image were classified into four types: PI-1 (diffuse uneven enhancement), PI-2 (spotty enhancement), PI-3 (peripheral enhancement), and PI-4 (negative enhancement). The incidence of PI-1, PI-2, PI-3, and PI-4 was 4.8%, 42.9%, 28.6%, and 23.8%, respectively. With respect to resectable cases, these enhancement patterns were compared with histological findings, i.e., the distribution of blood vessels in the tumor, remaining pancreatic tissues in the tumor, differentiation of types of adenocarcinoma, volume of stroma, and invasion types of carcinoma. The enhanced patterns consequently corresponded to either the distribution of the blood vessels or the remaining pancreatic tissues in the tumor.
CONCLUSION: This study indicated that pancreatic ductal carcinoma is frequently enhanced by microbubbles, and the signals seem to originate from fine blood vessels and the remaining pancreatic tissues in the tumor.

Entities:  

Keywords:  agent detection imaging, Levovist; contrast-enhanced sonography; pancreatic ductal carcinoma

Year:  2006        PMID: 27277616     DOI: 10.1007/s10396-005-0058-7

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  12 in total

1.  Sonographic diagnosis of pancreatic islet cell tumor: value of intermittent harmonic imaging.

Authors:  H Ding; M Kudo; H Onda; H Nomura; S Haji
Journal:  J Clin Ultrasound       Date:  2001-09       Impact factor: 0.910

2.  Recent advances in US diagnosis of pancreatic cancer.

Authors:  Y Hirooka; H Goto; A Ito; S Hashimoto; T Hirai; K Niwa; K Takeda; T Hayakawa
Journal:  Hepatogastroenterology       Date:  2001 Jul-Aug

3.  Classification of ultrasonographic images of small hepatocellular carcinoma using galactose-based contrast agent: relation between image patterns and histologic features.

Authors:  Yasuo Matsuda; Iwao Yabuuchi; Toshikazu Ito; Ryoichi Arima
Journal:  J Med Ultrason (2001)       Date:  2004-09       Impact factor: 1.314

4.  Qualitative diagnosis of hepatocellular carcinoma by contrast enhanced ultrasonography using Coded Harmonic Angio with Levovist.

Authors:  Toshiko Hirai; Hajime Ohishi; Etsuko Tokuno; Miho Takahashi; Hiroshi Sakaguchi; Hiroshi Anai; Yuko Nishimoto; Shinji Hirohashi; Kimihiko Kichikawa
Journal:  J Med Ultrason (2001)       Date:  2002-03       Impact factor: 1.314

5.  Detection of tumor vascularity in hepatocellular carcinoma with contrast-enhanced Dynamic Flow imaging: Comparison with contrast-enhanced power Doppler imaging.

Authors:  Yan Ling Wen; Masatoshi Kudo; Yasunori Minami; Hobyung Chung; Yoichiro Suetomi; Hirokazu Onda; Masayuki Kitano; Toshihiko Kawasaki; Kiyoshi Maekawa
Journal:  J Med Ultrason (2001)       Date:  2003-09       Impact factor: 1.314

6.  Echo-enhanced color- and power-Doppler EUS for the discrimination between focal pancreatitis and pancreatic carcinoma.

Authors:  D Becker; D Strobel; T Bernatik; E G Hahn
Journal:  Gastrointest Endosc       Date:  2001-06       Impact factor: 9.427

7.  Histological influence on contrast-enhanced CT of pancreatic ductal adenocarcinoma.

Authors:  H Demachi; O Matsui; S Kobayashi; Y Akakura; K Konishi; M Tsuji; A Miwa; S Miyata
Journal:  J Comput Assist Tomogr       Date:  1997 Nov-Dec       Impact factor: 1.826

8.  Evaluation of blood flow in pancreatic ductal carcinoma using contrast-enhanced, wide-band Doppler ultrasonography: correlation with tumor characteristics and vascular endothelial growth factor.

Authors:  Tadashi Ohshima; Taketo Yamaguchi; Takeshi Ishihara; Masaharu Yoshikawa; Akitoshi Kobayashi; Nobuyuki Sakaue; Takeshi Baba; Syuji Yamada; Hiromitsu Saisho
Journal:  Pancreas       Date:  2004-04       Impact factor: 3.327

9.  Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions.

Authors:  K Takeda; H Goto; Y Hirooka; A Itoh; S Hashimoto; K Niwa; T Hayakawa
Journal:  Acta Radiol       Date:  2003-01       Impact factor: 1.990

10.  Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent.

Authors:  Michitaka Nagase; Junji Furuse; Hiroshi Ishii; Masahiro Yoshino
Journal:  J Ultrasound Med       Date:  2003-08       Impact factor: 2.153

View more
  2 in total

1.  Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.

Authors:  Katsufumi Mizushige; Kazushi Murakami; Teppei Tsuji; Isao Kondo; Xie Lu; Atsufumi Tomohiro
Journal:  J Med Ultrason (2001)       Date:  2008-12-16       Impact factor: 1.314

2.  A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography.

Authors:  Junko Fukuda; Sachiko Tanaka; Nobuko Ishida; Tatsuya Ioka; Kenji Ikezawa; Rena Takakura; Miho Nakao; Kazuyoshi Ohkawa; Kazuhiro Katayama; Shigenori Nagata
Journal:  J Med Ultrason (2001)       Date:  2018-02-22       Impact factor: 1.314

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.